Cargando…
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
Chronic kidney disease (CKD) is a global health problem, affecting more than 850 million people worldwide. The number of patients receiving renal replacement therapy (dialysis or renal transplantation) has increased over the years, and it has been estimated that the number of people receiving renal...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300572/ https://www.ncbi.nlm.nih.gov/pubmed/35583597 http://dx.doi.org/10.1007/s40620-022-01336-7 |